Zobrazeno 1 - 6
of 6
pro vyhledávání: ''
Autor:
Noriyuki Nakayama, Toru Iwama, Jun Shinoda, Hirohito Yano, Kazuhiro Miwa, Naoyuki Ohe, Yuichi Nomura
Publikováno v:
Brain Tumor Pathology. 32:253-260
Anaplastic oligoastrocytoma (AOA) with necrosis is classified as glioblastoma (GBM) with oligodendroglioma component (GBMO), according to the 2007 World Health Organization classification. The prognosis of GBMO remains controversial because definitiv
Publikováno v:
Brain Tumor Pathology. 32:202-209
Wilms' tumour-1 (WT-1) protein m-RNA was recently demonstrated in meningiomas, suggesting the potential application of WT-1 immunotherapy in these tumours. The aim of the present study was to analyze the immunohistochemical expression of WT-1 protein
Autor:
Junko Matsuyama, Yugo Kishida, Yosuke Kuromi, Masahiro Ichikawa, Tomoyoshi Oikawa, Jun Sakuma, Yuka Matsumoto, Takuya Maeda, Keiko Oda, Hitoshi Ando, Kiyoshi Saito, Masayuki Yamada, Taku Sato
Publikováno v:
Brain Tumor Pathology. 31:222-228
We report 2 cases of primary central nervous system (CNS) lymphoma arising in the region of the optic nerve. For both patients, diagnosis of lymphoma was impossible without histological examination because of the rarity of the lymphoma location. The
Publikováno v:
Brain Tumor Pathology. 27:95-101
Malignant astrocytomas are characterized by diffusely infiltrating nature, and the abnormality of p53 is a cytogenetic hallmark of astrocytic tumors. To elucidate the relationship between p53 abnormality and invasiveness of the tumors, we studied mut
Autor:
Takahito Miyazawa, Akiko Yano, Hiroshi Katoh, Hiroshi Nawashiro, Nobusuke Tsuzuki, Namiko Nomura, Naoki Otani, Akira Ohnuki, Shinji Fukui, Katsuji Shima, Shoichiro Ishihara
Publikováno v:
Brain Tumor Pathology. 19:23-29
The aim of this study was to assess the subcellular localization of basic fibroblast growth factor (bFGF) and fibroblast growth factor receptor 1 (FGFR1) in pituitary adenomas. We studied 61 patients who had primary pituitary adenomas and underwent o
Publikováno v:
Brain Tumor Pathology. 18:23-28
We investigated stereotactic intratumoral microinfusion of nimustine (ACNU) in recurrent brain tumors. Eligibility required histologic confirmation of glioma recurrence despite standard radiotherapy and chemotherapy as well as enhancement of the recu